ARTICLE | Company News
AMAG Pharmaceuticals, Takeda sales and marketing update
May 27, 2013 7:00 AM UTC
AMAG disclosed in an SEC filing that partner Takeda is recalling a batch of anemia drug Rienso ferumoxytol from the Swiss market. According to AMAG, the decision was based on four reports of hypersensitivity reactions, including one fatality. AMAG said the companies are investigating the recalled batch of the IV iron replacement therapy, which the company said only affects the Swiss market, and the reported adverse events. ...